Press Release GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) 14 May 2025
Press Release Reply Presents “App to the Future”: A New AI-Scape Room Experience Powered by Microsoft AI and Low-Code Solutions 14 May 2025
Press Release Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS 14 May 2025
Press Release KRAFTON to Launch Abyss of Dungeons in Southeast Asia and Latin America in June 14 May 2025
Press Release Introducing Encompass™: A Breakthrough Solution from Mirvie to Advance Care for Pregnancy Complications 14 May 2025
Press Release Humanetics Unveils New Safety Organizational Structure to Enhance Customer Focus and Product Innovation 14 May 2025
Press Release Hugh & Grace Named 2025’s Most Transformative and Fastest Growing Impact Company 14 May 2025
